MAS1 and metabolic dysfunction-associated steatohepatitis: Our data, however, clearly show that WD suppression of hepatic ω3 and ω6 PUFA and oxylipin content precedes WD-mediated induction of the major hepatic events linked to NASH, such as MAS and fibrosis.